Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New decision tree aims to standardize care for common spine fractures

NCT ID NCT07706439

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 15, 2026 · Last updated Jul 17, 2026 · Updated 2 times

Summary

This study tests a clinical decision tree designed to guide treatment for low-energy vertebral compression fractures—common in older adults. The tree uses patient age, MRI findings, pain level, and bone deformity to recommend either vertebroplasty or conservative care. Researchers will track fracture healing and complications in 400 patients to see if this structured approach improves outcomes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a clinical decision tree for management (including vertebroplasty or conservative care)
What this could lead to
If successful, this could provide a standardized, evidence-based approach to treating vertebral fractures, potentially improving healing rates and reducing unnecessary procedures.
What could go wrong
This is an observational evaluation, not a randomized trial, so it cannot prove the decision tree is better than other approaches. Results may not apply to all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 400 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Jul 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

In this study, all patients treated for one or more low-energy vertebral compression fractures (LEVCFs) in the Department of Orthopedic Surgery and Traumatology at Grenoble Alpes University Hospital, according to the clinical decision tree, between January 1, 2022, and March 31, 2025, will be eligible for inclusion.

Ages

18 to 100 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age \> 50 years * One or more low-energy vertebral compression fractures (LEVCFs) confirmed by MRI * Fractures located between T7 and L5 * Compression fractures classified as A1.1, A1.2, or A1.3 according to the Magerl classification \[15\] * Management in accordance with the clinical decision tree * Vertebroplasty performed by an interventional radiologist, orthopedic surgeon, or neurosurgeon * Vertebral augmentation performed by an orthopedic surgeon or neurosurgeon, with or without navigation assistance * Conservative treatment consisting of a lumbar brace worn during daytime, with duration individualized according to the patient's needs, and physiotherapy initiated between 45 and 90 days after treatment, including core stabilization, stretching, and strengthening of the posterior muscle chain and abdominal muscles, based on active rehabilitation rather than manual therapy (no massage therapy). Exclusion Criteria: * Pregnant or breastfeeding women * Individuals under administrative or judicial supervision * Age \< 50 years or \> 90 years * Pathological vertebral fracture * Presence of other osteoporotic fractures during the study follow-up period (6 months) * Non-compliance with the clinical decision tree * Dementia or cognitive impairment preventing data collection at the final follow-up (telephone interview), assessed using the Mini-Cog test (score \< 3 = exclusion) * Refusal to participate during the telephone interview or inability to provide non-opposition (e.g., under legal guardianship)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Thoracolumbar low-energy vertebral compression fractures are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Grenoble Alpes university Hospital

    La Tronche, 38700, France